A research team has demonstrated a comprehensive high-throughput phenotyping (HTPP) platform integrated with metabolomics, transcriptomics, and ...

NervGen Pharma Corp., a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other neurologic disorders, announced its second ...

A faith-based investment firm partnered with S&P Dow Jones Indices to create a new index and exchange traded fund (ETF) that will cater to evangelical Christian investors. Bountiful Financial and S&P ...

Plasmodesmata are channels that allow cell-cell communication in plants; based on the functional similarities between facilitated transport within plasmodesmata and into the nucleus, the authors ...

Plasma p-tau181 is a promising biomarker that can help identify Alzheimer's disease pathology and distinguish those who are ...

Learn everything you need to know about SPDR® Portfolio S&P 500 Value ETF (SPYV) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold ...

In statistical practice P-values are regularly used to express the amount of evidence in the data, but there is no agreement on how to compute two-sided P-values when the sampling distributions are ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

The world's largest Bitcoin treasury firm, Strategy (Nasdaq: MSTR), formerly MicroStrategy, could join the S&P 500 list as early as this Friday, the popular Bitcoin investor Lark Davis said on Sep. 1.

Learn everything you need to know about SPDR® S&P 600 Small Cap Value ETF (SLYV) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's ...

The field of RNA bioinformatics is undergoing a transformative era marked by substantial advancements in sequencing technologies and data acquisition ...